SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank43
3Y CAGR-4.0%
5Y CAGR+3.5%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-4.0%/yr
vs -7.8%/yr prior
5Y CAGR
+3.5%/yr
Recent deceleration
Acceleration
+3.8pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 5.77% |
| 2024 | 13.74% |
| 2023 | 13.60% |
| 2022 | 6.52% |
| 2021 | 7.90% |
| 2020 | 4.85% |
| 2019 | 11.33% |
| 2018 | 9.01% |
| 2017 | 2.46% |
| 2016 | 5.58% |